Related Experiment Videos
Alpha 2-adrenoceptors and endothelium-derived relaxing factor
1Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minnesota 55905.
The American Journal of Medicine
|September 18, 1989
Summary
The endothelium releases endothelium-derived relaxing factor (EDRF) that inhibits vasoconstriction. Alpha 2-adrenergic agonists can cause relaxation via EDRF release or contraction by acting on smooth muscle receptors.
Area of Science:
- Vascular Biology
- Endothelial Function
- Pharmacology
Background:
- The endothelium produces vasodilators like prostacyclin and endothelium-derived relaxing factor (EDRF).
- EDRF release is triggered by shear stress, neurotransmitters, hormones, and platelet products.
- Endothelium-dependent responses to catecholamines involve alpha 2-adrenoceptors on endothelial cells.
Purpose of the Study:
- To investigate the dual role of alpha 2-adrenergic agonists on vascular tone.
- To elucidate the mechanisms by which endothelial cells modulate alpha 2-adrenergic responses.
Main Methods:
- Examined endothelium-dependent relaxations induced by selective alpha 2-adrenergic agonists in blood vessels.
- Assessed the influence of endothelial cells on the vasoconstrictor effects of alpha 2-adrenergic agonists.
Main Results:
- Selective alpha 2-adrenergic agonists can induce endothelium-dependent relaxations, particularly in high-flow vessels.
- Alpha 2-adrenergic agonists also stimulate postsynaptic receptors on vascular smooth muscle, causing contraction.
- The vasoconstrictor response to alpha 2-adrenergic agonists is sensitive to EDRF, with endothelial cells blunting this effect.
Conclusions:
- Endothelial cells play a crucial role in modulating vascular responses to alpha 2-adrenergic stimuli.
- The presence of endothelium can inhibit vasoconstriction through augmented EDRF release and increased sensitivity to EDRF's inhibitory effects.